
Pulmonary arterial hypertension (PAH) is a progressive disease characterized by elevated pulmonary arterial pressure and subsequent right heart failure. These changes result from pulmonary vasculature wall thickening and remodelling. Interestingly, the epidemiology of PAH reveals a fourfold greater disease prevalence in females than males, accompanied by a reciprocal increase of disease severity in males versus females. Insights into the sexual dimorphism observed in PAH may lead to the development of better therapeutics, as current therapies are not curative. But, the mechanism(s) underlying these gender differences remain poorly understood.
Like
Save
Share